- Report
- August 2022
- 115 Pages
Global
From €3966EUR$4,500USD£3,451GBP
- Report
- August 2022
- 117 Pages
Global
From €3966EUR$4,500USD£3,451GBP
- Report
- August 2022
- 118 Pages
Global
From €3966EUR$4,500USD£3,451GBP
- Report
- August 2022
- 116 Pages
Global
From €3966EUR$4,500USD£3,451GBP
- Report
- August 2022
- 116 Pages
Global
From €3966EUR$4,500USD£3,451GBP
- Report
- August 2022
- 119 Pages
Global
From €3966EUR$4,500USD£3,451GBP
- Report
- October 2021
- 100 Pages
Global
From €3966EUR$4,500USD£3,451GBP
- Report
- October 2021
- 113 Pages
Global
From €3966EUR$4,500USD£3,451GBP
- Report
- May 2024
- 139 Pages
Global
From €5727EUR$6,499USD£4,984GBP
- Report
- December 2021
- 163 Pages
Global
From €3922EUR$4,450USD£3,413GBP
From €2622EUR$2,975USD£2,281GBP
€3084EUR$3,500USD£2,684GBP
- Report
- April 2025
- 70 Pages
Saudi Arabia
From €2622EUR$2,975USD£2,281GBP
€3084EUR$3,500USD£2,684GBP
- Report
- February 2025
- 85 Pages
India
From €2622EUR$2,975USD£2,281GBP
€3084EUR$3,500USD£2,684GBP
- Report
- December 2024
- 85 Pages
India
From €2622EUR$2,975USD£2,281GBP
€3084EUR$3,500USD£2,684GBP
- Report
- November 2024
- 82 Pages
Vietnam
From €2622EUR$2,975USD£2,281GBP
€3084EUR$3,500USD£2,684GBP
- Report
- April 2024
- 181 Pages
Global
From €3371EUR$3,825USD£2,933GBP
€3966EUR$4,500USD£3,451GBP
- Report
- April 2024
- 186 Pages
Global
From €3371EUR$3,825USD£2,933GBP
€3966EUR$4,500USD£3,451GBP
- Report
- February 2024
- 190 Pages
Global
From €3371EUR$3,825USD£2,933GBP
€3966EUR$4,500USD£3,451GBP
- Report
- February 2024
- 185 Pages
Global
From €3371EUR$3,825USD£2,933GBP
€3966EUR$4,500USD£3,451GBP
- Report
- August 2023
- 74 Pages
Turkey
From €2622EUR$2,975USD£2,281GBP
€3084EUR$3,500USD£2,684GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more